🇺🇸 FDA
Pipeline program

ZULRESSO®

547-PPD-404

Approved small_molecule completed

Quick answer

ZULRESSO® for Postpartum Depression is a Approved program (small_molecule) at SUPERNUS PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
SUPERNUS PHARMACEUTICALS, INC.
Indication
Postpartum Depression
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials